Institute Director: Professor Tariq Enver
Deputy Director and Clinical Lead: Professor Jonathan Ledermann
The UCL Cancer Institute is a £40 million investment in central London based at University College London (UCL), one of the world’s top universities and a founding member of the Crick Institute. The Institute draws together over 400 scientists working together to develop world-class basic and translational cancer research.
UCL Cancer Institute is structured around five research departments that span our three Institute sites at UCL and the Royal Free Hospital:
- Cancer Biology - Dept. Head: Professor Henning Walczak
- Clinical Trials - Dept. Head: Professor Jonathan Ledermann
- Haematology - Dept. Head: Professor Karl Peggs
- Oncology - Dept. Head: Professor Daniel Hochhauser
- Pathology - Dept. Head: Professor Adrienne Flanagan
Clinical and interdisciplinary networks
Through our associations with UCL Hospitals NHS Foundation Trust, Great Ormond Street Hospital and the Royal Free Hospital NHS Foundation Trust, the Institute has greater clinical links than any comparable centre in the UK and a significant impact on the delivery of clinical service to cancer patients. This concentration of excellence, access to patients and significant recent investment of cancer treatment and research infrastructure, makes UCL a global leader.
UCL Cancer Institute exemplifies UCL’s distinctive cross-disciplinary approach, bringing together varied disciplinary expertise and theoretical perspectives to advance our understanding of the complexities of cancer and the development of improved diagnostics and treatments.